Cas­sa­va says two se­nior em­ploy­ees in­clud­ed in fed­er­al probes

Fol­low­ing years of ac­cu­sa­tions of sci­en­tif­ic malfea­sance, Alzheimer’s drug de­vel­op­er Cas­sa­va Sci­ences dis­closed Mon­day that two of its se­nior em­ploy­ees are be­ing in­ves­ti­gat­ed by the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.